Antibiotics Flashcards

1
Q

how can antibiotics enter cells?

A
  1. Passive diffusion
    • antibiotic = lipophilic
    • crosses cell membrane of bacteria
    • Harder through gram -ve (2 membranes)
  2. Active transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

4 main mechanisms by which microorganisms exhibit resistance to antimicrobials

A
  1. porins
  2. pumps
  3. metabolism
  4. mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are porins?

A

channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are porins used to help microorganisms exhibit resistance to antimicrobials?

A

Reduce drug access or drug accumulation by reducing drug permeability

Fewer pores = more resistant to antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is p-glycoprotein 1 also known as?

A

multidrug resistance protein 1, MDR1

ATP-binding cassette sub-family B member 1
ABCB1

cluster of differentiation 243, CD243

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is p-glycoprotein?

A

a glycoprotein that in humans is encoded by ABCB1 gene and is a well characterised ABC transporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how are pumps used to help microorganisms exhibit resistance to antimicrobials?

A

Increase active efflux of the drugs across cell wall

Prevent therapeutic conc. from being achieved (= correct dose required)

If bacteria can pump out antibiotic, therapeutic concentration reached + target cell not killed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is metabolism used to help microorganisms exhibit resistance to antimicrobials?

A

Drug inactivation or modification

Hydrolysis of other amides/esters

Oxidative demethylation catalysed CYP450 also brings resistance
-OH, -NH, -SH (i.e. key alkyl groups)
removed via metabolism

Metabolise instead of pump -> via enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how are mutations used to help microorganisms exhibit resistance to antimicrobials?

A

Alteration of target site

increase no. of possible binding sites (dilute antibiotic effect)

alteration of biosynthetic pathways and biosynthetic requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is VRE?

A

[Vancomycin-resistant enterococci]

Bacterial strains of the genus Enterococcus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does Enterococcus become VRE?

A

vancomycin-sensitive enterococci obtain new DNA in the form of plasmids or transposons, which encode genes that confer vancomycin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where are VRE outbreaks most common?

A

hospitals

Can be carried by healthy people who have come into contact with the bacteria (most likely in hospital -> nosocomial infection; also some in factories)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the 6 types of vancomycin resistance shown by enterococcus?

A

Van-A/B/C/D/E/F

Only Van-A/B/C have been seen in general clinical practice so far

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is Van-A resistant to?

A

both vancomycin and teicoplanin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Van-B resistant to?

A

Resistant to vancomycin

Sensitive to teicoplanin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is Van-C resistant to?

A

Partly resistant to vancomycin

Sensitive to teicoplanin

17
Q

what is Linezolid?

A

commonly used to treat VRE as teicoplanin is not available

Resistance within 2 years of discovery via 1 of 4 mechanisms

18
Q

Mechanism of resistance to vancomycin in Enterococcus

A

Alteration of the terminal amino acid residues of the NAM/NAG-peptide subunits

Under normal conditions, vancomycin binds to D-Alanyl-D-Alanine

19
Q

D-Alanyl-D-Alanine mutation

A

O for NH

Results in loss of 1 hydrogen-bonding interaction (4 instead of 5) being possible for vancomycin and new peptide (ester)

Loss of 1 points of interaction results in a 1000-fold decrease in affinity

20
Q

D-Ala-D-Ser variation

A

causes a 6-fold loss of affinity between vancomycin and peptide, likely due to steric hinderance

21
Q

what are the implications of vancomycin resistance?

A

Vancomycin = last antibiotic

When this is lost, we lose surgery in hospitals/transplants

= post antibiotic era

22
Q

what is Vaborbactam?

A

Potent broad-spectrum non-β-lactam β-lactamase inhibitor

23
Q

what is Vaborbactam used for?

A

Not effective as an antibiotic itself, it restores potency to existing antibiotics by inhibiting β-lactamase enzymes that would otherwise degrade them

When combined with an appropriate antibiotic, it can be used for the treatment of gram-negative bacterial infections

24
Q

Vaborbactam + carbapenem antibiotic combination

A

met all pre-specified primary endpoints in a phase 3 trial in patients with complicated urinary tract infections (cUTIs)

25
Q

serine carbapenemases

A

= family of β-lactamase enzymes

distinguished by their broad spectrum of activity and their ability to degrade carbapenem antibiotics

26
Q

what is serine carbapenemases used for?

A

treatment of multidrug-resistant gram-negative infections

27
Q

Vaborbactam specificity

A

higher affinity of human hydrolases for linear substrates similar to their endogenous substrates and low affinity for a cyclic boronate ester, like vaborbactam

28
Q

what are sulfonamides?

A

group of antibiotics

29
Q

what is MRSA?

A

resistant to penicillin

30
Q

how does the target cell prevent therapeutic conc. from being achieved?

A

makes copies of target

survive because they can make more resistant copies

NOT by altering target